Saturna Capital Corp Horizon Therapeutics Public LTD CO Transaction History

Saturna Capital Corp

  • $7.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$62.39 - $113.8 $42,113 - $76,815
-675 Reduced 3.75%
17,325 $1.97 Million
Q3 2022

Nov 10, 2022
SELL
$58.92 - $84.67 $194,436 - $279,411
-3,300 Reduced 15.49%
18,000 $1.11 Million
Q2 2022

Aug 12, 2022
BUY
$79.4 - $116.36 $1.69 Million - $2.48 Million
21,300 New
21,300 $1.7 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email